Skip to main content

Table 4 The primary outcome measures of the FACT-B and the FACT-Cog in the treatment subgroups

From: Cancer treatment regimens and their impact on the patient-reported outcome measures health-related quality of life and perceived cognitive function

Variable

G

Mean (SD)

n

Change

(%)

IG T*

F–T

F–G

F–GxT

η2

(T)

η2

(GxT)

T0

T1

FACT-B

(0–148)

SC

114.5 ± 13.9

98.8 ± 14.7

22

− 13.2 ± 11.9

a

82.62***

0.17NS

4.12**

0.52

0.14

SCR

116.7 ± 12.1

94.8 ± 18.9

17

− 18.6 ± 13.8

a

     

SR

113.5 ± 16.9

103.8 ± 19.2

27

− 8.8 ± 8.6

a

     

S

111.4 ± 9.1

103.5 ± 13.4

13

− 7.3 ± 7.5

a

     

PWB

(0–28)

SC

24.7 ± 2.1

19.8 ± 4.9

22

− 19.5 ± 20.5

a

70.47***

1.35NS

2.26NS

0.48

0.08

SCR

23.9 ± 2.9

16.8 ± 6.3

17

− 29.7 ± 23.4

a

     

SR

24.0 ± 3.8

20.0 ± 5.2

27

− 16.7 ± 17.0

a

     

S

24.1 ± 2.8

21.3 ± 4.1

13

− 11.5 ± 12.9

a

     

SWB

(0–28)

SC

23.0 ± 3.4

20.2 ± 3.4

22

− 11.5 ± 14.4

a

36.35***

0.86NS

2.60NS

0.33

0.09

SCR

24.8 ± 3.0

21.0 ± 3.9

17

− 15.3 ± 10.8

a

     

SR

22.4 ± 3.9

21.3 ± 5.0

27

− 4.2 ± 20.1

      

S

21.8 ± 3.5

19.9 ± 5.0

13

− 9.1 ± 17.2

      

EWB

(0–24)

SC

15.2 ± 4.8

15.7 ± 3.9

22

+ 7.7 ± 29.9

 

0.47NS

0.09NS

0.16NS

0

0

SCR

15.8 ± 3.1

15.7 ± 3.5

17

+ 0.7 ± 20.1

      

SR

15.1 ± 4.6

15.5 ± 4.9

27

+ 3.4 ± 22.2

      

S

15.9 ± 2.9

16.0 ± 2.5

13

+ 1.3 ± 8.2

      

FWB

(0–28)

SC

19.4 ± 6.5

15.7 ± 5.4

22

− 16.7 ± 15.5

a

51.36***

0.33NS

3.25*

0.41

0.12

SCR

20.9 ± 5.2

16.1 ± 4.3

17

− 19.8 ± 20.5

a

     

SR

20.0 ± 4.7

17.7 ± 4.4

27

− 10.3 ± 11.9

a

     

S

18.8 ± 3.8

17.5 ± 3.3

13

− 5.4 ± 12.5

      

BCS

(0–40)

SC

32.0 ± 3.5

27.5 ± 4.8

22

− 14.1 ± 12.3

a

76.11***

1.03NS

3.98*

0.5

0.13

SCR

31.4 ± 4.4

25.2 ± 6.3

17

− 19.7 ± 14.8

a

     

SR

32.0 ± 4.1

29.3 ± 5.5

27

− 9.1 ± 10.7

a

     

S

30.8 ± 4.1

28.7 ± 5.0

13

− 6.8 ± 10.6

a

     

FACT-

SC

118.1 ± 13.4

100.4 ± 11.8

22

− 14.9 ± 6.0

a

168.53***

1.64NS

27.93***

0.69

0.53

Cog

(0–132)

SCR

117.9 ± 11.8

93.6 ± 13.8

17

− 20.5 ± 9.4

a

     

SR

116.3 ± 14.5

110.9 ± 18.4

27

− 5.1 ± 6.6

a

     

S

116.9 ± 18.6

114.5 ± 14.9

13

− 1.3 ± 6.5

      

PCI

(0–72)

SC

64.2 ± 10.0

56.7 ± 9.1

22

− 11.6 ± 5.0

a

118.70***

1.09NS

15.07***

0.61

0.38

SCR

64.8 ± 7.4

52.9 ± 9.2

17

− 18.1 ± 11.6

a

     

SR

64.5 ± 7.7

61.1 ± 9.8

27

− 5.6 ± 7.1

a

     

S

64.5 ± 10.0

62.8 ± 8.3

13

− 2.2 ± 7.1

      

OTH

(0–16)

SC

15.5 ± 1.0

13.7 ± 2.0

22

− 11.9 ± 11.7

a

55.83***

1.14NS

10.82***

0.43

0.3

SCR

15.4 ± 1.5

13.1 ± 1.7

17

− 15.0 ± 9.5

a

     

SR

15.6 ± 0.8

15.2 ± 0.9

27

− 2.0 ± 5.7

      

S

15.7 ± 0.6

15.4 ± 1.0

13

− 1.9 ± 5.1

      

PCA

(0–28)

SC

25.1 ± 3.2

20.6 ± 3.2

22

− 17.2 ± 11.4

a

91.45***

0.76NS

17.40***

0.55

0.41

SCR

24.1 ± 3.2

19.6 ± 3.0

17

− 18.4 ± 7.8

a

     

SR

23.4 ± 4.8

22.6 ± 5.1

27

− 3.6 ± 8.3

a

     

S

24.2 ± 4.5

23.7 ± 4.0

13

− 1.7 ± 6.7

      

QoL

(0–16)

SC

13.3 ± 2.8

9.3 ± 1.9

22

− 28.2 ± 14.0

a

85.35***

1.44NS

22.49***

0.53

0.47

SCR

13.6 ± 2.6

8.0 ± 1.9

17

− 39.2 ± 17.1

a

     

SR

12.8 ± 3.4

11.9 ± 4.2

27

− 8.2 ± 20.1

      

S

12.5 ± 4.6

12.7 ± 3.0

13

+ 1.8 ± 14.6

      
  1. Data are expressed as means ± standard deviation (SD); Change in percent (%) represent the average score change of each patient
  2. For FACT-B and FACT-Cog, higher scores indicate a subjectively better HRQoL or PCF
  3. SC, Surgery + Chemotherapy; SCR, Surgery + Chemotherapy + Radiation Therapy; SR, Surgery + Radiation Therapy; S, Surgery; n, number of patients; NS, not significant; T, time; G, group; F–T, main effect for time group; F–G, main effect for group regardless of the time; GxT, interaction between time and group; IG T, individual group for time
  4. *p < 0.05; **p < 0.01; ***p < 0.001
  5. "a" expresses statistically significant effects (p < 0.05) from basline to T1 of each group of the variable